Track the Biofrontera Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €21.4m. The latest transaction was filed on 29 July 2026 (Levée d'options). Among the most active insiders: Luebbert Hermann. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biofrontera Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$5.88.
Fundamental score
Ranked 24,997 of 29,063 companies
25.9
score / 100
Value
5
Quality
47
FCF yld-57%
Earn yld-45%
EV/EBITDA·
ROE·
Gross mgn74%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Biofrontera Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades de la piel. Se especializa en soluciones innovadoras para el tratamiento del cáncer de piel y otras afecciones dermatológicas.